High-throughput, Quantitative Analyses of Genetic Interactions in E. Coli
Overview
Pathology
Authors
Affiliations
Large-scale genetic interaction studies provide the basis for defining gene function and pathway architecture. Recent advances in the ability to generate double mutants en masse in Saccharomyces cerevisiae have dramatically accelerated the acquisition of genetic interaction information and the biological inferences that follow. Here we describe a method based on F factor-driven conjugation, which allows for high-throughput generation of double mutants in Escherichia coli. This method, termed genetic interaction analysis technology for E. coli (GIANT-coli), permits us to systematically generate and array double-mutant cells on solid media in high-density arrays. We show that colony size provides a robust and quantitative output of cellular fitness and that GIANT-coli can recapitulate known synthetic interactions and identify previously unidentified negative (synthetic sickness or lethality) and positive (suppressive or epistatic) relationships. Finally, we describe a complementary strategy for genome-wide suppressor-mutant identification. Together, these methods permit rapid, large-scale genetic interaction studies in E. coli.
Rachwalski K, Madden S, Ritchie N, French S, Bhando T, Girgis-Gabardo A iScience. 2024; 27(10):110894.
PMID: 39376497 PMC: 11456916. DOI: 10.1016/j.isci.2024.110894.
CRISPRi-TnSeq maps genome-wide interactions between essential and non-essential genes in bacteria.
Jana B, Liu X, Denereaz J, Park H, Leshchiner D, Liu B Nat Microbiol. 2024; 9(9):2395-2409.
PMID: 39030344 PMC: 11371651. DOI: 10.1038/s41564-024-01759-x.
Parkhill S, Johnson E Biochem J. 2024; 481(13):839-864.
PMID: 38958473 PMC: 11346456. DOI: 10.1042/BCJ20220062.
Synthetic lethality and the minimal genome size problem.
Rahiminejad S, De Sanctis B, Pevzner P, Mushegian A mSphere. 2024; 9(7):e0013924.
PMID: 38904396 PMC: 11288024. DOI: 10.1128/msphere.00139-24.
CRISPRi functional genomics in bacteria and its application to medical and industrial research.
Enright A, Heelan W, Ward R, Peters J Microbiol Mol Biol Rev. 2024; 88(2):e0017022.
PMID: 38809084 PMC: 11332340. DOI: 10.1128/mmbr.00170-22.